Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.36
+0.19 (3.68%)
Jul 6, 2026, 2:24 PM EDT - Market open
Zura Bio Employees
Zura Bio had 40 employees as of December 31, 2025. The number of employees increased by 10 or 33.33% compared to the previous year.
Employees
40
Change (1Y)
10
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,653,350
Market Cap
509.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 40 | 10 | 33.33% | 40 | 0 |
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Sutro Biopharma | 133 |
| Ocugen | 116 |
| C4 Therapeutics | 104 |
| Silence Therapeutics | 88 |
| Prelude Therapeutics | 79 |
| Rezolute | 68 |
| Prothena Corporation | 67 |
ZURA News
- 5 days ago - Zura Bio Slides: Corporate presentation - Filings
- 7 days ago - Zura Bio exceeds enrollment target in HS, SSc Phase 2 studies - TheFly
- 7 days ago - Zura Bio sees cash runway through the end of 2028 - TheFly
- 7 days ago - Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program - Business Wire
- 4 weeks ago - Zura Bio Slides: Corporate presentation - Filings
- 6 weeks ago - Zura Bio Proxy statement: Proxy filing - Filings
- 7 weeks ago - Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Zura Bio names Muzammil Mustufa chief business officer - TheFly